Alta Partners this week announced the promotion of Alison de Bord to director. She joins six other Alta directors responsible for investing at Alta Partners. She currently represents Alta as a director on the boards of Aegerion Pharmaceuticals, Insulet, and SurgRx and was directly involved in Alta’s investments in Esperion Therapeutics and Kerberos Proximal Solutions.
De Bord has an MBA from Columbia University and a BA in history from Colgate University.
Alta also announced Adam Tomasi has joined the firm as a Kaufman fellow. He had been a student at the Harvard-Massachusetts Institute of Technology Biomedical Enterprise Program and completed his PhD at the University of California, Irvine.
GWC Technologies announced this week the appointment of Timothy Stultz to its board of directors. Stultz is the president and CEO of Imago Scientific Instruments. Stultz was also the founder and President of Peak Systems and president and CEO of ThauMDx.
GWC, based in Madison, Wis., develops and manufactures label-free analysis systems for proteomics, drug discovery, genomics, protein array development, and materials science research.